Veterinary Medicines

Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
Pulmotil AC 250 mg/mL concentrate for oral solution for use in drinking water or milk replacer for chickens, turkeys, pigs and calves
Pulmotil AC 250 mg/ml concentraat voor orale oplossing voor gebruik in drinkwater voor kippen, varkens, kalkoenen, of in kunstmelk voor kalveren
Active substance:
  • Tilmicosin
Target species:
  • Chicken
  • Turkey
  • Pig
  • Cattle (pre-ruminant)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tilmicosin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Meat and offal
        12
        day
    • Turkey
      • Meat and offal
        19
        day
    • Pig
      • Meat and offal
        14
        day
    • Cattle (pre-ruminant)
      • Meat and offal
        42
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:
  • Polyethylene naphthalate amber coloured bottle containing 960 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.
  • Polyethylene naphthalate amber coloured bottle containing 240 mL of veterinary medicinal product, with a polypropylene screw top and polyethylene/aluminium/polyethylene terephthalate seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9972
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0102/001
Concerned member states:
  • Belgium
  • Greece
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 18/02/2024
Download
Dutch (PDF)
Published on: 24/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."